A Leader in Scientific Breakthroughs
BrightFocus Foundation is a premier private funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. We are currently managing a nearly $65 million global portfolio of more than 260 scientific projects.
Recently Funded
Learn more about grants awarded in the most current fiscal year. More than $25 million in funding for 106 new awards in FY2021.
Apply for a Grant
To start a new application and upload attachments, you must use our ProposalCentral application portal to apply online. Click one of the links to proceed to the RFPs.
Latest News
A new oral pill for geographic atrophy is being tested in an early-stage clinical trial.
In recognition of his critical discoveries in Alzheimer’s disease research, BrightFocus scientific alumnus Donald Weaver, MD, PhD, a clinical neurologist at the University of Toronto, has been awarded a prestigious silver-level Oskar Fischer Prize for introducing the unconventional hypothesis that Alzheimer’s disease is an autoimmune disorder.
BrightFocus Foundation, a leading nonprofit funder of vision research, has announced a request for proposals for scientific projects supported through its National Glaucoma Research (NGR) program. The application deadline is October 25, 2022, for projects beginning in 2023.
BrightFocus Foundation’s Alzheimer’s Disease Research program announced a request for scientific proposals for promising research on Alzheimer’s disease and related dementias. The application deadline is November 1, 2022, for projects beginning in 2023.